| Financial Year |
March 31 2023 |
| Monetary Funds |
1,635,379,442.61 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
167,239,221.67 |
| Advances to Suppliers |
3,023,883.15 |
| Other Receivables |
594,125,456.78 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
-- |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
439,350,740.01 |
| Total Current Assets |
2,839,118,744.22 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
832,779,920.73 |
| Investment Properties |
3,928,837,471.47 |
| Fixed Assetes |
166,669,749.00 |
| Under-construction Projects |
1,248,490,536.48 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
85,154,750.50 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
17,076,918.50 |
| Deferred Income Tax Assets |
26,036,118.10 |
| Other Non-Current Assets |
1,880,600.00 |
| Sub-Total of Non-Current Assets |
7,883,232,226.30 |
| Total Assets |
10,722,350,970.52 |
| Short-Term Loans |
1,070,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
33,680,204.08 |
| Accounts Received In Advance |
2,610,596,420.93 |
| Employee Compensation Payable |
9,365,238.61 |
| Taxes Payable |
196,467,597.33 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
276,892,350.37 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
172,607.53 |
| Sub-Total of Current Liabilities |
4,215,017,290.70 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
138,847,841.69 |
| Other Non-Current Liabilities |
490,000.00 |
| Sub-Total of Non-Current Liabilities |
153,888,657.53 |
| Total Liabilities |
4,368,905,948.23 |
| Paid-In Capital(Or Share Stock) |
1,465,790,928.00 |
| Capital Surplus |
1,134,726,025.87 |
| Surplus Reserve |
455,136,243.86 |
| LESS:Treasury Stock |
481,088,322.71 |
| Undistributed Profits |
3,125,480,824.70 |
| Minority Stockholder's Interest |
236,855,797.45 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,116,589,224.84 |
| Owner's Equity（Stockholder's Equity） |
6,353,445,022.29 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,722,350,970.52 |
